HEAD AND NECK CANCER
Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).Read more...

Join our subscribers list to get the latest news, updates and special offers directly in your inbox